A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Robert Wesolowski, Daniel G. Stover et al.|Investigational New Drugs|2020Cited by 37
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerSagar Sardesai, Bhuvaneswari Ramaswamy, Jasmine Sukumar et al.|Cardio-Oncology|2020Cited by 32
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective studyEvan Morgan, Maryam B. Lustberg, Anupama Suresh et al.|World Journal of Surgical Oncology|2020Cited by 31
TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the LiteratureH. Boutrid, Mathew Cherian, Mahmoud Kassem et al.|Frontiers in Endocrinology|2020Cited by 20
Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of ExperienceHannah Rinehardt, Anne M. Noonan, Mahmoud Kassem et al.|European Journal of Breast Health|2021Cited by 11